| WhiteHawk Limited (WHK) ORDINARY FULLY PAID |
Information Technology |
$9 |
General Meeting Presentation
|
11 Feb 2025 8:15AM |
$0.011 |
$0.012 |
risen by
9.09%
|
|
| Xref Limited (XF1) ORDINARY FULLY PAID |
Information Technology |
$41 |
Becoming a substantial holder
|
11 Feb 2025 8:15AM |
$0.125 |
$0.185 |
risen by
48%
|
|
| Audinate Group limited (AD8) ORDINARY FULLY PAID |
Information Technology |
$561 |
Ceasing to be a substantial holder
|
11 Feb 2025 8:15AM |
$7.250 |
$6.730 |
fallen by
7.17%
|
|
| Region Group (RGN) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$2,635 |
Results Half Year 31 December 2024 Investor Presentation
|
11 Feb 2025 8:15AM |
$2.180 |
$2.270 |
risen by
4.13%
|
|
| Region Group (RGN) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$2,635 |
Half Year 31 December 2024 Announcement
|
11 Feb 2025 8:14AM |
$2.180 |
$2.270 |
risen by
4.13%
|
|
| Mineral Resources Limited (MIN) ORDINARY FULLY PAID |
Materials |
$5,426 |
Becoming a substantial holder
|
11 Feb 2025 8:14AM |
$35.050 |
$27.610 |
fallen by
21.23%
|
|
| Region Group (RGN) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$2,635 |
Results Half Year 31 December 2024 and Appendix 4D
|
11 Feb 2025 8:14AM |
$2.180 |
$2.270 |
risen by
4.13%
|
|
| Mader Group Limited (MAD) ORDINARY FULLY PAID |
Industrials |
$1,411 |
1H FY25 Results Announcement and Briefing Details
|
11 Feb 2025 8:14AM |
$6.150 |
$6.990 |
risen by
13.66%
|
|
| Nexus Minerals Limited (NXM) ORDINARY FULLY PAID |
Materials |
$41 |
Regional Aircore Drilling Underway at Wallbrook Gold Project
|
11 Feb 2025 8:14AM |
$0.053 |
$0.068 |
risen by
28.30%
|
|
NXM - Price-sensitive ASX Announcement
Full Release
Key Points
- Nexus Minerals has started a regional aircore drilling program at the Wallbrook Gold Project.
- The drilling will test high-priority gold anomalies identified in previous exploration.
- The program covers a strike length of about 8km within the Wallbrook tenement package.
- Targets have been prioritized based on structural setting, geochemistry, and geophysical data.
- The program is intended to expand gold resources and identify new zones of mineralization.
- Drilling will complement earlier work and help define next steps for further exploration.
- The Wallbrook Gold Project is situated northeast of Kalgoorlie in Western Australia.
- The company emphasizes its commitment to ongoing exploration success and resource growth.
- Results from the drilling campaign will be reported as they become available.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ordell Minerals Limited (ORD) ORDINARY FULLY PAID |
Materials |
$14 |
Ordell Consolidates Land Holding Around Goodia Project
|
11 Feb 2025 8:14AM |
$0.360 |
$0.400 |
risen by
11.11%
|
|
| Winsome Resources Limited (WR1) ORDINARY FULLY PAID |
Materials |
$50 |
Amended announcement
|
11 Feb 2025 8:13AM |
$0.450 |
$0.205 |
fallen by
54.44%
|
|
| Indiana Resources Limited (IDA) ORDINARY FULLY PAID |
Materials |
$56 |
Details of Company Address
|
11 Feb 2025 8:13AM |
$0.072 |
$0.087 |
risen by
20.83%
|
|
| Macquarie Group Limited (MQG) ORDINARY FULLY PAID |
Financials |
$85,524 |
Macquarie Group 3Q25 Trading Update Presentation
|
11 Feb 2025 8:13AM |
$227.890 |
$224.390 |
fallen by
1.54%
|
|
MQG - Price-sensitive ASX Announcement
Full Release
Key Points
- Annuity-style businesses showed substantial growth in 3Q25.
- Macquarie Asset Management reached AUM of $A942.7b.
- Banking and Financial Services experienced growth in home loans and deposits.
- Markets-facing businesses faced challenges due to subdued commodity markets.
- Net profit contribution from markets-facing businesses significantly down.
- Overall net profit after tax is in line with FY24.
- Cautious outlook due to market volatility and regulatory changes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Breville Group Limited (BRG) ORDINARY FULLY PAID |
Consumer Discretionary |
$4,245 |
Half Year Ended 31 December 2024 - Investor Presentation
|
11 Feb 2025 8:13AM |
$37.720 |
$29.490 |
fallen by
21.82%
|
|
BRG - Price-sensitive ASX Announcement
Full Release
Key Points
- Solid 10.1% sales growth against backdrop of resilient consumer demand
- 13.0% Global Product segment sales growth in constant currency
- All three Theatres in double-digit sales growth (Global Segment constant currency), led by strong Coffee growth across all Theatres
- Gross Margin % held steady with 10.3% Gross Profit dollar growth
- EBIT growth of 10.5% with expenses growth aligned to Gross Profit growth
- NPAT growth of 16.1% with lower interest cost arising from strong PY cash generation
- Tactical pull forward of 2H25 inventory in the US as a hedge against tariff risk
- Aggregate of other countries’ inventory held broadly flat
- Low leverage and strong cashflow provides funding flexibility for further expansion and investment
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Breville Group Limited (BRG) ORDINARY FULLY PAID |
Consumer Discretionary |
$4,245 |
Dividend/Distribution - BRG
|
11 Feb 2025 8:12AM |
$37.720 |
$29.490 |
fallen by
21.82%
|
|
| Breville Group Limited (BRG) ORDINARY FULLY PAID |
Consumer Discretionary |
$4,245 |
Half Year Ended 31 December 2024 - Report Announcement
|
11 Feb 2025 8:12AM |
$37.720 |
$29.490 |
fallen by
21.82%
|
|
BRG - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue grew by 10.1% to AUD 997.5 million.
- NPAT increased by 16.1% to AUD 97.5 million.
- Gross margin remained steady at 36.7%.
- Strong growth in the Coffee category drove revenue.
- Interim dividend declared at 18.0 cents per share.
- Expecting EBIT growth of 5%-10% for FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Breville Group Limited (BRG) ORDINARY FULLY PAID |
Consumer Discretionary |
$4,245 |
Half Year Ended 31 December 2024 - Appendix 4D
|
11 Feb 2025 8:12AM |
$37.720 |
$29.490 |
fallen by
21.82%
|
|
BRG - Price-sensitive ASX Announcement
Full Release
Key Points
- Total sales revenue increased by 10.1% to A$997,518,000.
- Net profit after tax rose by 16.1% to A$97,515,000.
- Operating expenses increased by 10.2%, aligned with gross profit growth.
- Gross profit increased by 10.3%, maintaining a gross margin of 36.7%.
- Interim dividend declared at 18.0 cents per share, up from 16.0 cents.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| CSL Limited (CSL) ORDINARY FULLY PAID |
Health Care |
$121,373 |
Dividend/Distribution - CSL
|
11 Feb 2025 8:11AM |
$270.340 |
$250.660 |
fallen by
7.28%
|
|
| Macquarie Group Limited (MQG) ORDINARY FULLY PAID |
Financials |
$85,524 |
Macquarie Group 3Q25 Trading Update ASX Release
|
11 Feb 2025 8:11AM |
$227.890 |
$224.390 |
fallen by
1.54%
|
|
MQG - Price-sensitive ASX Announcement
Full Release
Key Points
- NPAT for the nine months to December 31, 2024, is broadly in line with FY24 YTD.
- Annuity-style businesses saw a substantial increase in net profit contribution due to volume growth.
- Banking and Financial Services experienced increased performance fees and investment income.
- Markets-facing businesses' net profit contribution decreased due to subdued conditions in commodity markets.
- Group capital surplus is $A8.5 billion, exceeding regulatory requirements.
- CET1 ratio was 12.6% and LCR was 196% as of December 31, 2024.
- Macquarie Group remains well-positioned for superior performance in the medium term.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| CSL Limited (CSL) ORDINARY FULLY PAID |
Health Care |
$121,373 |
CSL Half Year Results Investor Presentation
|
11 Feb 2025 8:11AM |
$270.340 |
$250.660 |
fallen by
7.28%
|
|
CSL - Price-sensitive ASX Announcement
Full Release
Key Points
- Half-year results for CSL Limited announced on 11 February 2025.
- Reported revenue of $8,483 million, a 5% increase from the previous year.
- Immunoglobulin sales increased by 15%, and albumin sales rose by 9%.
- Seqirus segment faced challenges due to low immunization rates.
- Financial guidance reaffirmed with projected NPATA growth of 10-13%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| CSL Limited (CSL) ORDINARY FULLY PAID |
Health Care |
$121,373 |
CSL Half Year Results Announcement
|
11 Feb 2025 8:11AM |
$270.340 |
$250.660 |
fallen by
7.28%
|
|
CSL - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported NPAT of $2.01 billion, up 7% on a constant currency basis.
- Revenue of $8.48 billion, reflecting a 5% increase.
- NPATA of $2.07 billion, up 5% at constant currency.
- Strong performance driven by CSL Behring and CSL Vifor.
- Revenue growth anticipated at approximately 5-7% for FY25.
- NPATA guidance set between $3.2 billion and $3.3 billion for FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| CSL Limited (CSL) ORDINARY FULLY PAID |
Health Care |
$121,373 |
CSL Statutory Accounts for the Half Year Ended 31 Dec 2024
|
11 Feb 2025 8:10AM |
$270.340 |
$250.660 |
fallen by
7.28%
|
|
CSL - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for the half year was US$8.48 billion, up 5% from the previous year.
- Net profit after tax (NPAT) attributable to members of the parent entity was US$2.01 billion, a 6% increase.
- CSL Behring's revenue increased by 10%, driven by strong immunoglobulin product sales.
- The company declared an unfranked interim dividend of US$1.30 per share.
- CSL expects revenue growth of approximately 5-7% for FY25 at constant currency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SGH Limited (SGH) ORDINARY FULLY PAID |
Industrials |
$20,643 |
Dividend/Distribution - SGH
|
11 Feb 2025 7:42AM |
$48.660 |
$50.720 |
risen by
4.23%
|
|
| Vulcan Steel Limited (VSL) ORDINARY FULLY PAID |
Materials |
$876 |
Dividend/Distribution - VSL
|
11 Feb 2025 7:32AM |
$6.800 |
$6.650 |
fallen by
2.21%
|
|
| Vulcan Steel Limited (VSL) ORDINARY FULLY PAID |
Materials |
$876 |
Half Year 2025 results announcement
|
11 Feb 2025 7:32AM |
$6.800 |
$6.650 |
fallen by
2.21%
|
|
VSL - Price-sensitive ASX Announcement
Full Release
Key Points
- Vulcan Steel Limited reported half year results for period ended 31 December 2023.
- Revenue and net profit declined compared to the prior corresponding period.
- Lower steel prices and softer demand in key markets affected performance.
- Company focused on cost management and operational efficiency.
- Ongoing investment in customer service and digital transformation initiatives.
- Board declared an interim dividend.
- Commitment to long-term growth strategy in Australia and New Zealand.
- Ongoing monitoring of market conditions and disciplined capital allocation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
